BGE-175, an oral drug that reverses multiple aspects of immune aging effectively prevents death in mouse models of COVID-19.
Study reveals how COVID-19's spike protein has a similar effect on the brain's immune cells as it does throughout the rest of the body.
During the early stages of the COVID pandemic, one in three new mothers reported experiencing postpartum depression, while 1 in 5 had symptoms of major depression. The risks were higher in mothers who formula-fed their infants, and in those whose children were in neonatal ICU.
Even mild COVID-19 infection can lead to cognitive alterations and brain shrinkage, researchers report. The findings could help explain the brain changes that contribute to long-COVID.
Regular exercise may break inflammation associated with long-COVID that leads to diabetes, depression, and cognitive impairment in the months following infection.
Researchers report some patients with long-COVID have lasting nerve damage that appears to be caused by infection-triggered immune dysfunction.
Pandemic associated risk factors for anxiety differ between men and women, researchers say. Higher anxiety in males was associated with COVID misinformation, while women's anxiety was more commonly associated with concerns about employment. Overall, the prevalence for general anxiety disorder was significantly higher in women than in men.
Cognitive deficits as a result of long-COVID can be significantly improved within 3 - 4 days following alternating non-invasive brain stimulation using microcurrents.
Cognitive shortcuts could explain why some people fail to adhere to recommendations to mask up and get vaccinated to protect against COVID infection.
The brains of patients who died as a result of COVID-19 infection displayed some of the same molecular changes found in the brains of those with Alzheimer's disease, a new small study found. The findings may explain why some long-term COVID sufferers report memory problems.
Infection with the SARS_CoV-2 virus causes dials down the action of olfactory receptors, resulting in smell loss associated with COVID-19.
Carnosic acid, a compound found in the herb rosemary, can block the interaction with the COVID-19 SARS_CoV_2 spike protein and ACE2, the protein receptor the virus uses to gain access into cells. The compound appears to have anti-inflammatory effects and has previously been associated with a reduction in Alzheimer's symptoms.
